|
USP28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.225900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.381200E-01 |
| Normal-vs-Stage2 |
4.453000E-01 |
| Normal-vs-Stage3 |
1.823200E-03 |
| Normal-vs-Stage4 |
1.428000E-02 |
| Stage1-vs-Stage2 |
8.467200E-01 |
| Stage1-vs-Stage3 |
1.285500E-02 |
| Stage1-vs-Stage4 |
1.294380E-01 |
| Stage2-vs-Stage3 |
5.548300E-02 |
| Stage2-vs-Stage4 |
1.725610E-01 |
| Stage3-vs-Stage4 |
7.164800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.203700E-02 |
| Normal-vs-AfricanAmerican |
5.900000E-01 |
| Normal-vs-Asian |
2.791400E-01 |
| Caucasian-vs-AfricanAmerican |
4.283200E-01 |
| Caucasian-vs-Asian |
5.902800E-01 |
| AfricanAmerican-vs-Asian |
7.368400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.736120E-02 |
| Normal-vs-Female |
1.155580E-01 |
| Male-vs-Female |
2.320200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.209000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.235700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.063900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.003800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.375000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.185700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.984300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.769800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.096840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.376200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.613400E-04 |
| Classical-VS-Follicular |
8.891800E-01 |
| Classical-VS-Other |
1.228240E-01 |
| Classical-VS-Normal |
1.742590E-01 |
| Tall-VS-Follicular |
3.195500E-03 |
| Tall-VS-Other |
9.698200E-01 |
| Tall-VS-Normal |
2.420000E-04 |
| Follicular-VS-Other |
2.293000E-01 |
| Follicular-VS-Normal |
3.433400E-01 |
| Other-VS-Normal |
3.970200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.818500E-02 |
| Normal-vs-N1 |
7.264300E-03 |
| N0-vs-N1 |
1.836380E-01 |
|
|
